Aug 4, 2025
In this mini focus issue of JACC This Week, Editor-in-Chief Dr.
Harlan Krumholz explores the evolving landscape of cardiac
amyloidosis care. From structural and biomarker findings in the
HELIOS-B substudy to broader discussions on access, treatment
sequencing, and multidisciplinary care, this episode highlights new
momentum in ATTR-CM management.
Also covered: a sham-controlled trial on compression therapy for
vasovagal syncope and pooled trial data on DOAC use in frail older
adults with atrial fibrillation. Fast-moving insights, practical
takeaways, and a clear message—amyloidosis is no longer rare and
mysterious, but a condition we can monitor, modify, and manage.